![Adam Stone](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Adam Stone
Directeur Général chez
LIANBIO
Fortune : 2 420 $ au 31/05/2026
Profil
Mr. Adam L.
Stone is a Chief Executive Officer & Director at Perceptive Capital Solutions Corp., a Chief Executive Officer & Director at LianBio, an Independent Director at Solid Biosciences, Inc., a Chief Investment Officer at Perceptive Advisors (Private Equity), a Chief Investment Officer at Perceptive Advisors LLC and a Chief Executive Officer & Director at Arya Sciences Holdings.
He is on the Board of Directors at Perceptive Capital Solutions Corp., Immatics NV, LianBio, Solid Biosciences, Inc., Perceptive Advisors LLC, Arya Sciences Holdings and Xontogeny LLC.
Mr. Stone was previously employed as a Chief Executive Officer & Director by ARYA Sciences Acquisition Corp.
V, a Chief Executive Officer & Director by ARYA Sciences Acquisition Corp.
IV, a Chief Executive Officer & Director by ARYA Sciences Acquisition Corp.
III, a Chief Executive Officer & Director by ARYA Sciences Acquisition Corp.
II, a Chief Executive Officer & Director by ARYA Sciences Acquisition Corp., and a Senior Analyst by Ursus Capital Management LLC.
He also served on the board at Prometheus Biosciences, Inc., Renovia, Inc. (MA) and PROMETHERA Biosciences SA. He received his undergraduate degree from Princeton University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
LIANBIO 0,02 % | 15/02/2024 | 17 082 ( 0,02 % ) | 2 420 $ | 31/05/2026 |
IMMATICS N.V. -.--% | 18/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| 10/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Adam Stone
| Sociétés | Poste | Début |
|---|---|---|
| SOLID BIOSCIENCES INC. | Directeur/Membre du Conseil | 01/11/2015 |
| IMMATICS N.V. | Directeur/Membre du Conseil | 01/07/2020 |
| LIANBIO | Directeur Général | 16/12/2023 |
Perceptive Advisors LLC
 Perceptive Advisors LLC Investment ManagersFinance Perceptive Advisors focuses on investment opportunities in healthcare, with an emphasis on biotechnology. The firm believes that significant opportunities exist in biotechnology due to pervasive underlying market inefficiencies and volatility. | Directeur en chef des Investissements | 01/05/2006 |
Arya Sciences Holdings
 Arya Sciences Holdings MiscellaneousMiscellaneous Operates as an investment holding company | Directeur Général | - |
Xontogeny LLC
 Xontogeny LLC Pharmaceuticals: MajorHealth Technology Operates biotech aggregator company | Directeur/Membre du Conseil | - |
Perceptive Advisors (Private Equity)
 Perceptive Advisors (Private Equity) Investment ManagersFinance Perceptive Advisors invests in both public and private middle market companies located across the globe. The firm focuses across a broad range of sectors and industries. It participates in seed, early, later stage and growth transactions in the form of equity and debt with an investment size of USD 10 – 300 million. The firm acts as lead investor and takes a seat on a board of directors. | Directeur en chef des Investissements | 01/05/2006 |
Anciens postes connus de Adam Stone
| Sociétés | Poste | Fin |
|---|---|---|
| ARYA SCIE | Fondateur | 01/08/2024 |
| ARYA SCIENCES ACQUISITION CORP V | Fondateur | 01/07/2023 |
| ░░░░ ░░░░░░░░ ░░░░░░░░░░░ ░░░ ░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Adam Stone
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
81
Relations au 1er degré
17
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 17 |
|---|---|
Perceptive Advisors LLC
Perceptive Advisors LLC Investment ManagersFinance Perceptive Advisors focuses on investment opportunities in healthcare, with an emphasis on biotechnology. The firm believes that significant opportunities exist in biotechnology due to pervasive underlying market inefficiencies and volatility. | Finance |
Ursus Capital Management LLC
 Ursus Capital Management LLC Investment ManagersFinance Ursus invests long/short in health technology companies. | Finance |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PROMETHERA Biosciences SA
 PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes cell therapy products to treat liver diseases | Health Technology |
Solid Biosciences, Inc.
 Solid Biosciences, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that develops treatments through gene therapy for patients with duchenne disease | Health Technology |
Perceptive Advisors (Private Equity)
Perceptive Advisors (Private Equity) Investment ManagersFinance Perceptive Advisors invests in both public and private middle market companies located across the globe. The firm focuses across a broad range of sectors and industries. It participates in seed, early, later stage and growth transactions in the form of equity and debt with an investment size of USD 10 – 300 million. The firm acts as lead investor and takes a seat on a board of directors. | Finance |
Prometheus Biosciences, Inc.
 Prometheus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops medicines for immune-mediated diseases | Health Technology |
Renovia, Inc. (MA)
 Renovia, Inc. (MA) Medical SpecialtiesHealth Technology Develops prescription digital therapeutic devices | Health Technology |
Xontogeny LLC
Xontogeny LLC Pharmaceuticals: MajorHealth Technology Operates biotech aggregator company | Health Technology |
ARYA Sciences Acquisition Corp.
 ARYA Sciences Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Arya Sciences Holdings
Arya Sciences Holdings MiscellaneousMiscellaneous Operates as an investment holding company | Miscellaneous |
Immatics NV
 Immatics NV Pharmaceuticals: MajorHealth Technology Engages in developing immunotherapies for cancer treatments | Health Technology |
ARYA Sciences Acquisition Corp. II
 ARYA Sciences Acquisition Corp. II Financial ConglomeratesFinance Operates as a blank check company | Finance |
ARYA Sciences Acquisition Corp. III
 ARYA Sciences Acquisition Corp. III Financial ConglomeratesFinance Operates as a blank check company | Finance |
LianBio
 LianBio BiotechnologyHealth Technology Operates as a biotechnology company focused on bringing paradigm-shifting medicines to patients | Health Technology |
ARYA Sciences Acquisition Corp. IV
 ARYA Sciences Acquisition Corp. IV Financial ConglomeratesFinance Operates as a blank check company | Finance |
ARYA Sciences Acquisition Corp. V
 ARYA Sciences Acquisition Corp. V Financial ConglomeratesFinance Operates as a blank check company | Finance |
